Search
for
Sort by
Research 241–270 of 503
- Dermatologic Adverse Events from Cancer Treatments
- Management of Toxicities of Targeted Therapies
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Current and future pharmacotherapy for alopecia areata
- Hair Growth After Gefitinib Treatment
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Efectos adversos dermatológicos con uso de litio
- Efficacy and safety of diode laser for facial hair reduction in hirsutism—a clinico-trichoscopic evaluation
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Retrospective Analysis of Systemic Corticosteroids for Alopecia Areata in Pediatric Patients
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Alopecia Areata
- Chemotherapy and Cutaneous Drug Reactions
- Adult Acne
- Diagnostic challenges in determining alopecia areata
- Scarring Alopecia
- Primary cicatricial alopecias
- Cutaneous drug reactions
- Skin Diseases in Pregnancy
- Atypical Morphological Patterns of Topical Steroid-Modified Dermatophytosis: A Cross-Sectional Study in South Asia
- Prevalence and Clinical Spectrum of Dermatologic Conditions in Renal Transplant Recipients: A 10-Year Retrospective Cross-Sectional Study
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Role of skin microbiome and exosomes in Hair regeneration and disorders in diseases like Alopecia, Acne: A comprehensive review
- Complications in follicular unit excision hair transplantation: current evidence and practical approaches
- Pharmacotherapy of alopecia areata
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Systemic corticosteroids in vitiligo: Evidence-based insights and practical considerations
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Safety and Clinical Efficacy of KūlarisTM, an Herbal Supplement for Mild to Severe Acne Vulgaris – A 12-Week Randomized, Double Blind, Placebo-Controlled Study
- A clinical study of pemphigus vulgaris and its variants, evaluation of safety and efficacy of glucocorticoids versus immunosuppressants at tertiary care hospital: a study of 75 cases